ACADIA Pharmaceuticals (NASDAQ:ACAD) Rating Increased to Buy at StockNews.com
StockNews.com upgraded shares of ACADIA Pharmaceuticals (NASDAQ:ACAD – Free Report) from a hold rating to a buy rating in a report published on Monday morning. A number of other analysts also recently commented on ACAD. Cantor Fitzgerald restated an overweight rating and set a $42.00 price target on shares of ACADIA Pharmaceuticals in a research […]
More Stories
J Heath Deneke Sells 1,000 Shares of Summit Midstream Corporation (NYSE:SMC) Stock
Summit Midstream Corporation (NYSE:SMC – Get Free Report) CEO J Heath Deneke sold 1,000 shares of the firm’s stock in...
Incyte Co. (NASDAQ:INCY) Receives Average Rating of “Hold” from Brokerages
Incyte Co. (NASDAQ:INCY – Get Free Report) has been assigned an average recommendation of “Hold” from the twenty ratings firms...
Eaton Co. plc (NYSE:ETN) Receives Average Rating of “Moderate Buy” from Brokerages
Eaton Co. plc (NYSE:ETN – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the seventeen...
NextEra Energy Partners, LP (NYSE:NEP) Given Consensus Recommendation of “Hold” by Analysts
NextEra Energy Partners, LP (NYSE:NEP – Get Free Report) has received a consensus rating of “Hold” from the seventeen analysts...
Analysts Set First Solar, Inc. (NASDAQ:FSLR) Target Price at $279.04
Shares of First Solar, Inc. (NASDAQ:FSLR – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the...
Real Good Food Company, Inc. Holds Special Meeting of StockholdersOn December 20, 2024, Real Good Food Company, Inc. (NASDAQ: RGF) conducted a virtual special meeting of stockholders to address key proposals. The meeting welcomed in-person and proxy
This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For...